Prognosis
Fauci Says Pfizer Vaccine’s Trial Success May Boost Acceptance
- Wariness for shots may have grown amid accelerated development
- Immunizations to begin in high-priority groups late next month
This article is for subscribers only.
We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.
The success of Pfizer Inc.’s Covid-19 vaccine trial may help persuade more people to get inoculated amid a surge in new coronavirus cases, according to Anthony Fauci, the top U.S. infectious-disease doctor.